Camden National director granted 275 shares on Sept. 18

Camden National Corp director Carl John Soderberg received 275 shares as director fee compensation under the 2022 Equity and Incentive Plan.

Available on EDGAR 09/22/2026 - 12:27 PM EDT Accepted by SEC EDGAR 09/22/2026 - 12:27 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CAMDEN NATIONAL CORP (CAC) director Carl John Soderberg reported receiving a grant of 275 shares of Common Stock on September 18, 2026. The shares were acquired at a reported value of $57.55 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees. Following this award, he directly holds 104,624.218 shares of Camden National common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 275 shares

Grant/Award 1 txn

Insider Soderberg Carl John

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common F1	275	$57.55	$16K

Holdings After Transaction: Common — 104,624.218 shares (Direct)

Footnotes (1)

1. F1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Key Figures

Shares acquired: 275 shares Grant value per share: $57.55 per share Shares owned after transaction: 104,624.218 shares +1 more

4 metrics

Shares acquired 275 shares Grant or award of Camden National Corp common stock on September 18, 2026

Grant value per share $57.55 per share Reported value for the 275-share award to Carl John Soderberg

Shares owned after transaction 104,624.218 shares Direct holdings of Camden National Corp common stock following the award

Number of acquire-type transactions 1 transaction Form 4 reports one non-derivative acquisition and no sales

Key Terms

2022 Equity and Incentive Plan, in lieu of director fees, Form 4

3 terms

2022 Equity and Incentive Plan financial

"Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan"

in lieu of director fees financial

"acquired under ... Equity and Incentive Plan and Amendment in lieu of director fees"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CAC director Carl John Soderberg report?

Carl John Soderberg reported an acquisition of 275 shares of Camden National Corp common stock on September 18, 2026, received as a grant or award rather than a market purchase.

At what value were the 275 CAC shares granted to Carl John Soderberg?

The 275 Camden National Corp shares were reported at $57.55 per share in the Form 4 filing, reflecting the value used for the grant or award on September 18, 2026.

How many CAC shares does Carl John Soderberg own after this Form 4 transaction?

After the reported award, Carl John Soderberg directly holds 104,624.218 shares of Camden National Corp common stock, according to the Form 4 data.

Was Carl John Soderberg’s CAC share grant under a compensation plan?

Yes. The 275 shares were acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees, as disclosed in the footnote.

Was the CAC Form 4 transaction made under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan applies to this transaction; the document-level 10b5-1 checkbox is not affirmed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Soderberg Carl John

(Last) (First) (Middle)

2 ELM STREET

PO BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	09/18/2026		A		275(1)	A	$57.55	104,624.218	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Remarks:

	Christopher G. Hutchinson, POA	09/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)